To investigate the impact of GLI1 and CCL20 on HCC progression and monocyte infiltration in vivo, we established PLC5 cell lines with homozygous knockout (KO) of GLI1 or CCL20 using the CRISPR/Cas9 technique. The gene discussed is CCL20; the disease is hepatocellular carcinoma.